Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Clinical trial NCT00052013 · COMPLETED
Trial details
- NCT number
- NCT00052013
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2006-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.